The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program StudyCarlo Visco, Ken H. Young, Emanuele S. G. d'Amore et al.|Blood|2011Cited by 5
Prognostic Significance and Phenotypic Manifestations of MYC/BCL2 Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) with Extranodal Organ Involvement: A Report of the International DLBCL Rituximab-CHOP Consortium Program StudyAnusha R. Madadi, Ken H. Young, Meghana Raghavendra et al.|Blood|2012Cited by 1